Disclosure Of Earnings Per Share [Text Block]

Innate Pharma - Filing #833782

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Disclosure of earnings per share [text block]
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
9.00
73.00
Basic earnings (loss) per share from discontinued operations
Basic earnings (loss) per share
9.00
73.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations
9.00
73.00
Diluted earnings (loss) per share from discontinued operations
Diluted earnings (loss) per share
9.00
73.00
Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]
Weighted average number of ordinary shares used in calculating diluted earnings per share
80 453 282 xbrli:shares
79 639 826 xbrli:shares
Disclosure of depositary receipts [text block]
Disclosure of depositary receipts [abstract]
Disclosure of depositary receipts [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.